UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Comparing NicoBloc to Nicotine Lozenges

Phase 2

Completed

Conditions: Smoking Cessation
Nicotine Dependence

Interventions: Drug: NicoBloc
Drug: Nicotine Lozenge

First Posted Date: 2018-10-25

Last Posted Date: 2025-04-08

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 45

Registration Number: NCT03720899

Locations: 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States

Baclofen as a Perioperative Analgesic Adjuvant

Phase 4

Recruiting

Conditions: Pain

Interventions: Drug: Baclofen 10mg
Other: Placebo

First Posted Date: 2018-10-25

Last Posted Date: 2023-09-26

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 86

Registration Number: NCT03720717

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: Choice
Behavioral: Pap testing

First Posted Date: 2018-10-22

Last Posted Date: 2022-11-16

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 335

Registration Number: NCT03713710

Locations: 🇺🇸
Mississippi State Department of Health, Jackson, Mississippi, United States

Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: Pap testing
Behavioral: Choice
Behavioral: Self-collection for HPV testing

First Posted Date: 2018-10-22

Last Posted Date: 2018-10-22

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 484

Registration Number: NCT03713697

Locations: 🇧🇷
Universidade Estadual de Maringá, Maringá, Paraná, Brazil

Influence of Obesity on Endogenous Oxalate Synthesis

Not Applicable

Recruiting

Conditions: Kidney Stone

Interventions: Dietary Supplement: controlled diet

First Posted Date: 2018-10-12

Last Posted Date: 2025-05-15

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT03704350

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Motivational Encouragement With Networks (MEN) for Healthy Eating Activity Resting Together (HEART) Health Study

Not Applicable

Completed

Conditions: Physical Activity

Interventions: Behavioral: Health coaching

First Posted Date: 2018-10-03

Last Posted Date: 2022-06-02

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 34

Registration Number: NCT03693768

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort

Phase 4

Completed

Conditions: Contact Lens Discomfort
Dry Eye

Interventions: Drug: Systane Complete

First Posted Date: 2018-09-25

Last Posted Date: 2020-04-06

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 46

Registration Number: NCT03682809

Locations: 🇺🇸
Southern College of Optometry, Memphis, Tennessee, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Lindenhurst Eye Physicians & Surgeons, P.C., Babylon, New York, United States

Comparison of Three Opioid Detoxification Treatment Regimens

Phase 3

Withdrawn

Conditions: Opioid-Related Disorders
Opioid Withdrawal

Interventions: Drug: Buprenorphine/naloxone
Drug: Morphine
Drug: Tramadol

First Posted Date: 2018-09-20

Last Posted Date: 2019-11-05

Lead Sponsor: University of Alabama at Birmingham

Registration Number: NCT03678792

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

Phase 2

Completed

Conditions: Alpha-1 Antitrypsin Deficiency (AATD)
Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I Mutations
Emphysema or COPD

Interventions: Drug: Alvelestat (MPH966)
Other: Placebo

First Posted Date: 2018-09-20

Last Posted Date: 2024-08-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 63

Registration Number: NCT03679598

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
The University of Alabama at Birmingham Lung Health Center, Birmingham, Alabama, United States

and more 7 locations

Impact of Glaucoma and Visual Field Loss on Life Space

Active, not recruiting

Conditions: Primary Open-angle Glaucoma

Interventions: Other: Questionnaires

First Posted Date: 2018-09-17

Last Posted Date: 2024-08-28

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 88

Registration Number: NCT03673644

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy